Business Wire

Neeva Launches in Europe to Rival Google Search With Tracking Free, Ad Free Search

Share

Search engine Neeva has today launched in Europe to rival Google, by giving web users honest search results, no tracking, and with absolutely no advertisements or affiliate links.

Neeva puts users first and gives consumers control to customise their web search experiences. By eschewing ads and advertisers, Neeva eliminates corporate bias that has plagued the traditional search experience. Instead, Neeva's sole goal is to create a search engine that delivers the best results as quickly as possible. Neeva delivers honest results and empowers users to select their information sources such as news outlets, shopping, software engineering sites, travel and others based on personal preference and relevance, rather than what advertisers suggest, all while respecting users’ privacy by blocking third party tracking and never profiting off of user data.

Neeva’s European expansion follows a successful 2021 $40mm Series B funding round. Founded by Sridhar Ramaswamy (ex-SVP of Ads at Google) and Vivek Raghunathan (ex-VP of Monetization at YouTube), Neeva is reinventing web search for good, challenging Google’s web-search dominance.

Commenting on Neeva’s launch, CEO, Sridhar Ramaswamy said: “Neeva is a user-first platform focused on private, transparent searches versus a search engine serving advertisers. The internet should be your private corner of the web instead of a barrage of ads, SEO spam and irrelevant information. We’re reinventing search by giving users control over sources; providing accurate and transparent results as well as private and customised experiences without the influence of corporate bias, tracked around the web.”

Neeva offers a freemium model and will first launch its private, ad-free free basic service in Europe, later introducing its premium subscription model with additional features such as a VPN and password manager. Neeva operates its own independent search stack, returning lightning fast results with high levels of accuracy, drawing from an index of billions of web pages. In addition, Neeva enables users to connect personal applications like email, Dropbox, Slack, Figma and others making it easy to search across the most important personal documents while maintaining strict privacy controls.

“Google has dominated the search engine market, maintaining over 90 percent market share. Neeva will challenge this supremacy by creating a better search and browse experience that delights users,” says Mr Ramaswamy. He added: “Users should be in control of their search and web experience rather than accepting one company deciding the information they see. The ad-supported internet, has created vastly misaligned incentives that have made Big Technology monopolies and advertisers richer while exploiting the privacy and personal data of users. It’s time for a new approach to search that puts people first.”

To date, search alternatives to Big Tech have mostly offered stronger privacy but at the expense of diminished search quality. Neeva is unique in building its own independent search stack (crawling, indexing and serving at scale) and without ads, freeing it to design user-first features with the sole focus of providing the best results in the most efficient way possible all with the strong privacy one should expect and demand from today’s internet experience.

Neeva is growing fast, gaining more than 600,000 monthly users since launching in the USA in 2021. Investors include Sequoia Capital, Greylock Ventures, Inovia Capital, and Neythri Futures Fund. The company has raised over $80m from its investors.

About Neeva

Neeva is the world’s first user-first private search engine. Neeva takes search back to its roots by focusing entirely on the user, delivering high quality results without any ads, giving users control over their sources, and protecting user privacy by blocking trackers. Neeva’s independent search stack offers rich visual experiences, integrates community forum content, and search over personal applications. Learn more and start searching today at neeva.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Ben Kobren
ben@neeva.co

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

HiddenA line styled icon from Orion Icon Library.Eye